Related Experiment Video
Updated: Jan 12, 2026

Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
Published on: February 5, 2019
Mitochondria-Targeted HA-Coated Nanosystem for ROS/CO Generation and Metabolic Reprogramming to Enhance Tumoricidal
Na Peng1,2, Chun Song1, Xiaoting Liu1
1Key Laboratory of Coal Conversion and New Carbon Materials of Hubei Province, School of Chemistry and Chemical Engineering, Wuhan University of Science and Technology, Wuhan 430081, China.
This study introduces a novel mitochondria-targeted nanosystem to reprogram tumor-associated macrophages (TAMs). The system effectively reduces M2-like TAMs and inhibits tumor growth by modulating the tumor microenvironment for enhanced immunotherapy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Immunotherapy
Background:
- Tumor-associated macrophage (TAM) polarization is a key factor in tumor progression and immune evasion.
- Targeting TAMs for repolarization offers a promising strategy for cancer immunotherapy.
- Mitochondrial dysfunction and reactive oxygen species (ROS) production are implicated in TAM polarization.
Purpose of the Study:
- To develop a mitochondria-targeted nanosystem for repolarizing TAMs and enhancing antitumor immunity.
- To investigate the efficacy of the nanosystem in modulating the tumor microenvironment and inhibiting tumor growth.
Main Methods:
- Synthesis of a mitochondria-targeted nanosystem (HA@MR@PCN-CORM) using zirconium-based metal-organic frameworks (PCN-224) loaded with a CO-releasing molecule (CORM-401).
- Surface modification with hyaluronic acid (HA) for CD44 receptor targeting and triphenylphosphine (TPP) for enhanced mitochondrial accumulation.
- In vitro and in vivo evaluation of TAM repolarization, ROS/CO generation, M2-like TAM depletion, and antitumor efficacy.
Main Results:
- The nanosystem efficiently targeted TAM mitochondria, inducing a ROS and CO storm upon laser irradiation, leading to 66.8% M2-like TAM killing.
- Significant repolarization of M1/M2-type TAMs (ratio increased from 0.29 to 1.20) and 93.4% tumor volume inhibition in vivo.
- Enhanced infiltration of cytotoxic T lymphocytes (CD3+/CD4+, CD3+/CD8+) and dendritic cells (DCs) in the tumor tissues.
Conclusions:
- The developed mitochondria-targeted nanosystem effectively depletes and modulates TAMs in an immunosuppressive tumor microenvironment.
- This strategy shows significant potential for enhancing antitumor therapy by reprogramming the tumor immune landscape.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against...

